Sweet Liking Phenotype, Alcohol Craving and Response to Naltrexone Treatment in Alcohol Dependence
Open Access
- 3 February 2009
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Alcohol and Alcoholism
- Vol. 44 (3), 293-300
- https://doi.org/10.1093/alcalc/agn122
Abstract
Aims: To investigate the relationship between the sweet liking/sweet disliking phenotype (a putative probe of brain opioid function), craving for alcohol and response to treatment with naltrexone in individuals with alcohol dependence. Methods: Forty individuals with alcohol dependence were enrolled in a 12-week open-label study of 50 mg of naltrexone with four sessions of motivational enhancement therapy. Prior to treatment, individuals completed a sweet preference test and the Penn Alcohol Craving Scale. Subjects were categorized as sweet liking (SL), n = 15, or sweet disliking (SDL), n = 25, via a standard sweet tasting paradigm. The sweet tasting results were blinded to the subjects and to treatment staff. SL status, pretreatment craving and their interaction were examined as predictors of frequency of abstinent days and heavy drinking days during treatment with naltrexone. Results: SL and SDL subjects achieved similar reductions in percent heavy drinking days with treatment. During treatment, SDL subjects had 48% abstinent days compared to 30% for SL subjects (P = 0.034). Pretreatment craving did not predict % heavy drinking days or % abstinent days. An interaction effect was found between the SL/SDL phenotype and pretreatment craving such that SL subjects with high craving demonstrated higher rates of percent abstinent days whereas SDL subjects with high craving demonstrated lower rates of percent abstinent days, P < 0.001. Conclusions: These findings indicate that the SL/SDL phenotype may predict variation in response to naltrexone and/or counseling treatment. Furthermore, the SL/SDL phenotype may interact with craving to provide a more robust prediction of outcome with naltrexone or counseling.Keywords
This publication has 60 references indexed in Scilit:
- An Evaluation of μ-Opioid Receptor (OPRM1) as a Predictor of Naltrexone Response in the Treatment of Alcohol DependenceArchives of General Psychiatry, 2008
- Moderators of Naltrexone’s Effects on Drinking, Urge, and Alcohol Effects in Non‐Treatment‐Seeking Heavy Drinkers in the Natural EnvironmentAlcohol: Clinical and Experimental Research, 2007
- Effects of Cigarette Smoking and Family History of Alcoholism on Sweet Taste Perception and Food Cravings in WomenAlcohol: Clinical and Experimental Research, 2007
- The Women's Recovery Group Study: A Stage I trial of women-focused group therapy for substance use disorders versus mixed-gender group drug counselingDrug and Alcohol Dependence, 2007
- Opioid Receptor Gene (OPRM1, OPRK1, and OPRD1) Variants and Response to Naltrexone Treatment for Alcohol Dependence: Results From the VA Cooperative StudyAlcohol: Clinical and Experimental Research, 2007
- A Functional Polymorphism of the μ‐Opioid Receptor Gene (OPRM1) Influences Cue‐Induced Craving for Alcohol in Male Heavy DrinkersAlcohol: Clinical and Experimental Research, 2006
- CLINICAL PREDICTORS OF RESPONSE TO NALTREXONE IN ALCOHOLIC PATIENTS: WHO BENEFITS MOST FROM TREATMENT WITH NALTREXONE?Alcohol and Alcoholism, 2005
- Association Between Sweet Preference and Paternal History of Alcoholism in Psychiatric and Substance Abuse PatientsAlcohol: Clinical and Experimental Research, 2003
- No Adjustments Are Needed for Multiple ComparisonsEpidemiology, 1990
- Different pituitary ß-endorphin and adrenal cortisol response to ethanol in individuals with high and low risk for future development of alcoholismLife Sciences, 1989